Corbus Pharmaceuticals Holdings, Inc. (CRBP): Price and Financial Metrics

CRBP POWR Grades

• CRBP scores best on the Growth dimension, with a Growth rank ahead of 83.24% of US stocks.
• CRBP's strongest trending metric is Quality; it's been moving up over the last 47 weeks.
• CRBP ranks lowest in Momentum; there it ranks in the 4th percentile.

CRBP Stock Summary

• With a year-over-year growth in debt of 203.61%, Corbus Pharmaceuticals Holdings Inc's debt growth rate surpasses 95.67% of about US stocks.
• As for revenue growth, note that CRBP's revenue has grown -62.93% over the past 12 months; that beats the revenue growth of merely 3.27% of US companies in our set.
• Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for CRBP comes in at -94.36% -- higher than that of just 2.24% of stocks in our set.
• Stocks with similar financial metrics, market capitalization, and price volatility to Corbus Pharmaceuticals Holdings Inc are PRQR, GLYC, MTEM, MEIP, and ZYME.
• CRBP's SEC filings can be seen here. And to visit Corbus Pharmaceuticals Holdings Inc's official web site, go to www.corbuspharma.com.

CRBP Valuation Summary

• In comparison to the median Healthcare stock, CRBP's price/sales ratio is 432.16% higher, now standing at 60.4.
• CRBP's price/sales ratio has moved NA NA over the prior 83 months.
• CRBP's price/earnings ratio has moved up 46.2 over the prior 83 months.

Below are key valuation metrics over time for CRBP.

CRBP Growth Metrics

• The year over year price growth rate now stands at -79.07%.
• The year over year net income to common stockholders growth rate now stands at -30.45%.
• The 3 year net income to common stockholders growth rate now stands at -587.86%.

CRBP's revenue has moved down $221,759 over the prior 33 months.

The table below shows CRBP's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-06-30	2.673207	-84.8155	-76.7108
2021-03-31	2.822995	-93.89405	-97.67775
2020-12-31	3.93723	-99.6857	-111.2694
2020-09-30	5.852546	-104.0233	-129.2382
2020-06-30	7.211708	-93.85688	-115.1337
2020-06-30	7.211708	-93.85688	-115.1337

CRBP's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• CRBP has a Quality Grade of C, ranking ahead of 46.81% of graded US stocks.
• CRBP's asset turnover comes in at 0.023 -- ranking 366th of 677 Pharmaceutical Products stocks.
• ARNA, ARWR, and MRSN are the stocks whose asset turnover ratios are most correlated with CRBP.

The table below shows CRBP's key quality metrics over time.